Ivan Zvyagin

6PUBLICATIONS
59CO-AUTHORS
Disease surveillanceInnate immunityAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Dec 09, 2022
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response.

Ksenia V Zornikova, Alexandra Khmelevskaya, Savely A Sheetikov

|Dec 08, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides.

Xinbo Yang, Lee I Garner, Ivan V Zvyagin

|Sep 15, 2022
Memory persistence and differentiation into antibody-secreting cells accompanied by positive selection in longitudinal BCR repertoires.

Artem Mikelov, Evgeniia I Alekseeva, Ekaterina A Komech

|Aug 15, 2022
VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2.

Mikhail Goncharov, Dmitry Bagaev, Dmitrii Shcherbinin

|Nov 18, 2020
T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αβ T cell-depleted hematopoietic stem cell transplantation.

Sergey Blagov, Ivan V Zvyagin, Larisa Shelikhova

Pageof 1

Frequent Collaborators

4 joint publications

Dmitry Chudakov

2 joint publications

Grigory A Efimov

2 joint publications

Ksenia V Zornikova

2 joint publications

Mikhail Shugay